|
|
Article: New Drug OK'd far Irritable Bowel Syndrome.(Lotronex)(Brief Article)
- Article from:
- FDA Consumer
- Article date:
- May 1, 2000
CopyrightCOPYRIGHT 2000 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Women with irritable bowel syndrome (IBS) whose primary symptom is diarrhea now have another option for treating their condition.
Alosetron hydrochloride (Lotronex) was approved by FDA in February to treat irritable bowel syndrome symptoms such as chronic or recurrent abdominal pain, diarrhea and constipation, and the sudden, urgent need to go to the bathroom.
IBS is a functional abnormality of the gastrointestinal tract that is estimated to affect up to 15 percent of Americans--women three times more often than men. Alosetron was not approved for and is not recommended for men.
Although how the drug works is not completely understood, alosetron ...